Individual Patient Data Meta-analysis on Prehospital Risk Assessment in Patients Suspected of Non-ST-segment Elevation Acute Coronary Syndrome
1 other identifier
interventional
5,239
1 country
1
Brief Summary
Patients with a non-ST-segment elevation acute coronary syndrome (NSTE-ACS) are currently transported and admitted to the nearest emergency department (ED) for risk stratification, diagnostic workup, and treatment. Recently, several prospective studies have been performed on the diagnostic performance of point-of-care (POC)-troponin and combined risk scores (CRS) for pre-hospital risk assessment and triage of NSTE-ACS patients. Also the first intervention trials on triage decisions based on POC troponin and CRS have been performed. Initial results are indicating that prehospital triage based on these diagnostic tools is feasible and safe, although sample sizes were relatively small and underpowered to detect differences in major adverse cardiac events (MACE). The objective of this individual patient data meta-analysis is to determine the diagnostic performance of POC troponin and combined risk scores for prehospital risk assessment and triage in suspected NSTE-ACS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2023
CompletedFirst Posted
Study publicly available on registry
September 22, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedMarch 18, 2026
March 1, 2026
1.2 years
September 4, 2023
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of participants with the diagnosis NSTE-ACS
Diagnosis of NSTE-ACS (NSTEMI or unstable AP) during index hospitalization (as assessed by the treating physician)
During index hospitalization, up to 1 day in the ED
MACE
All cause death, myocardial infarction, revascularization
Within 30 days
Secondary Outcomes (14)
MACE
1 week
All cause death
Within 30 days and 1 year follow-up
The number of participants undergoing invasive coronary angiography
During or after index hospitalisation, up to 30 days
The number of participants undergoing coronary revascularisation
During or after index hospitalisation, up to 30 days
Alternative diagnoses other than NSTE-ACS
during 30 day follow-up after inclusion
- +9 more secondary outcomes
Study Arms (3)
Usual care
OTHERPatients who receive usual care by EMS protocols
point-of-care troponin
OTHERPatients in who risk-stratification was performed by the use of a point-of-care troponin in the EMS setting
Combined risk scores
OTHERPatients in who risk-stratification was performed by the use of a combined risk score in the EMS setting
Interventions
Prehospital risk stratification by the use of a combined clinical risk score including POC-troponin
Prehospital risk stratification by the use of a POC-troponin
Eligibility Criteria
You may qualify if:
- Patients suspected for NSTE-ACS;
- Prospective study
- Original data
- Presenting prehospital (EMS)
- Prehospital risk assessment using at least POC-troponin, performed and analyzed by EMS.
- Outcome data available on in-hospital ACS or MACE within 30 days.
You may not qualify if:
- Enrolling only a specific subpopulation from the general ACS population
- Studies with less than 100 patients
- Studies enrolling only patients with STEMI.
- Studies published before 1995 / the pre-troponin era
- Studies performed by general practitioners.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catharina hospital Eindhoven
Eindhoven, Netherlands
Related Publications (5)
Demandt JPA, Zelis JM, Koks A, Smits GHJM, van der Harst P, Tonino PAL, Dekker LRC, van Het Veer M, Vlaar PJ. Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis. BMJ Open. 2022 Apr 5;12(4):e057305. doi: 10.1136/bmjopen-2021-057305.
PMID: 35383078BACKGROUNDSagel D, Vlaar PJ, van Roosmalen R, Waardenburg I, Nieuwland W, Lettinga R, van Barneveld R, Jorna E, Kijlstra R, van Well C, Oomen A, Bartels L, Anthonio R, Hagens V, Hofma S, Gu Y, Drenth D, Addink R, van Asselt T, van der Meer P, Lipsic E, Juarez Orozco L, van der Harst P. Prehospital risk stratification in patients with chest pain. Emerg Med J. 2021 Nov;38(11):814-819. doi: 10.1136/emermed-2020-210212. Epub 2021 Aug 9.
PMID: 34373266BACKGROUNDCamaro C, Aarts GWA, Adang EMM, van Hout R, Brok G, Hoare A, Rodwell L, de Pooter F, de Wit W, Cramer GE, van Kimmenade RRJ, Damman P, Ouwendijk E, Rutten M, Zegers E, van Geuns RM, Gomes MER, van Royen N. Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial. Eur Heart J. 2023 May 14;44(19):1705-1714. doi: 10.1093/eurheartj/ehad056.
PMID: 36755110BACKGROUNDTolsma RT, Fokkert MJ, van Dongen DN, Badings EA, van der Sluis A, Slingerland RJ, van 't Riet E, Ottervanger JP, van 't Hof AWJ. Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study. Eur Heart J Acute Cardiovasc Care. 2022 Feb 8;11(2):160-169. doi: 10.1093/ehjacc/zuab109.
PMID: 34849660BACKGROUNDDemandt JPA, Koks A, Haest R, Heijmen E, Thijssen E, Otterspoor LC, van Veghel D, El Farissi M, Eerdekens R, Vervaat F, Pijls NHJ, Veer MVT, Tonino PAL, Dekker LRC, Vlaar PJ. Prehospital triage of patients with suspected non-ST-segment elevation acute coronary syndrome: Rationale and design of the TRIAGE-ACS study. Contemp Clin Trials. 2022 Aug;119:106854. doi: 10.1016/j.cct.2022.106854. Epub 2022 Jul 18.
PMID: 35863696BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pieter-Jan Vlaar, MD, PhD
Catharina Ziekenhuis Eindhoven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 4, 2023
First Posted
September 22, 2023
Study Start
October 1, 2023
Primary Completion
December 1, 2024
Study Completion
January 1, 2026
Last Updated
March 18, 2026
Record last verified: 2026-03